martes, 2 de septiembre de 2014

National Guideline Clearinghouse | Guidelines by Topic: Ovarian Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Ovarian Neoplasms



Health Awareness Topics - September 2014

National Guideline Clearinghouse (NGC)

Guidelines by Topic

Ovarian Neoplasms (38)
Search within:    
Sort results by:      


Filter results by: 
1-20 of 38   Next >
 
2. 
Management of epithelial ovarian cancer. A national clinical guideline. 2003 Oct (revised 2013 Nov). NGC:010080
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
3. 
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer. 2013 May. NGC:009893
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
4. 
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer. 2013 May. NGC:009894
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5. 
Epithelial ovarian, fallopian tube, and primary peritoneal cancer. 2010 Jul (revised 2013 Apr). NGC:010253
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
6. 
NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.2007 Jun (revised 2013 Apr). NGC:009736
National Society of Genetic Counselors - Medical Specialty Society. View all guidelines by the developer(s)
7. 
Ovarian germ cell tumours. 2012 Apr (revised 2013 Apr). NGC:010263
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
8. 
Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. 1996 (revised 2012 Dec 18). NGC:009318
U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s)
9. 
Cancer screening. 2004 May (revised 2012 Oct). NGC:009352
University of Michigan Health System - Academic Institution. View all guidelines by the developer(s)
10. 
11. 
ACR Appropriateness Criteria® clinically suspected adnexal mass. 1996 (revised 2012). NGC:009674
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
12. 
ACR Appropriateness Criteria® ovarian cancer screening. 1996 (revised 2012). NGC:009255
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
13. 
ACR Appropriateness Criteria® staging and follow-up of ovarian cancer. 1996 (revised 2012). NGC:009250
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
14. 
Early detection of cancers. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009647
Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s)
15. 
Optimal chemotherapy for recurrent ovarian cancer. 2001 Sep 21 (revised 2011 Nov 21). NGC:009858
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
16. 
Management of suspected ovarian masses in premenopausal women. 2011 Nov. NGC:008987
British Society for Gynecological Endoscopy - Medical Specialty Society; Royal College of Obstetricians and Gynaecologists - Medical Specialty Society. View all guidelines by the developer(s)
17. 
Management of a suspicious adnexal mass. 2011 Jul 7. NGC:008822
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
18. 
Ovarian cancer. The recognition and initial management of ovarian cancer. 2011 Apr. NGC:008756
National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
19. 
20. 
Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. 1996 Feb (revised 2011). NGC:008496
Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. View all guidelines by thedeveloper(s)
1-20 of 38   Next >
21-38 of 38   < Previous
 
21. 
The role of IMRT in gynecologic cancers. 2010 Oct 29. NGC:008827
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
22. 
Cancer screening. 2010 Feb. NGC:009537
Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
23. 
24. 
ACR–ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.1996 (revised 2010). NGC:008422
American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s)
25. 
Ovarian carcinoma. 2009 Oct 1. NGC:008147
Comprehensive Cancer Centre the Netherlands - Disease Specific Society. View all guidelines by the developer(s)
26. 
Gynaecological ultrasound examination. 2001 Jan 5 (revised 2009 Sep 24). NGC:008185
Finnish Medical Society Duodecim - Professional Association. View all guidelines by the developer(s)
27. 
Initial evaluation and referral guidelines for management of pelvic/ovarian masses. 2009 Jul. NGC:007380
Gynecologic Oncologists of Canada - Disease Specific Society; Society of Canadian Colposcopists - Professional Association; Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society. View all guidelines by the developer(s)
28. 
Hereditary breast and ovarian cancer syndrome. 2009 Apr. NGC:007204
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s)
29. 
SAGES guidelines for the use of laparoscopic ultrasound. 2009 Mar. NGC:007265
Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. View all guidelines by thedeveloper(s)
30. 
PET imaging in ovarian cancer: recommendations. 2009 Jan 19. NGC:007452
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
32. 
Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. 2009. NGC:007630
National Academy of Clinical Biochemistry - Professional Association. View all guidelines by the developer(s)
33. 
Elective and risk-reducing salpingo-oophorectomy. 1999 Sep (revised 2008 Jan; reaffirmed 2012). NGC:006287
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s)
34. 
Management of adnexal masses. 2007 Jul (reaffirmed 2011). NGC:006539
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s)
35. 
36. 
Contraception for women aged over 40 years. 2005 Jan (revised 2010 Jul). NGC:008191
Faculty of Sexual and Reproductive Healthcare - Professional Association. View all guidelines by the developer(s)
37. 
Noncontraceptive uses of hormonal contraceptives. 2010 Jan. NGC:007532
American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s)
38. 
Guidelines on testicular cancer. 2001 (revised 2011 Mar). NGC:008600
European Association of Urology - Medical Specialty Society. View all guidelines by the developer(s)

No hay comentarios:

Publicar un comentario